Sign Up

EBAC

COM:LSPVC

EQT Life Sciences

  • Stock

Last Close

11.71

02/03 21:00

Market Cap

183.50M

Beta: -

Volume Today

77.64K

Avg: -

OverviewAnalysisMetricsFinancialsFilingspeopleAPIChartData
Income StatementBalance SheetCash FlowKey MetricsRatios
Quarterly
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '21
Dec '22
net income
1.48M
-
342.89K
76.81%
depreciation and amortization
deferred income tax
stock based compensation
change in working capital
386.01K
-
2.30M
496.66%
accounts receivables
inventory
accounts payables
57.91K
-
301.63K
420.91%
other working capital
328.10K
-
2.00M
510.03%
other non cash items
-2.55M
-
-3.16M
23.78%
net cash provided by operating activities
-688.83K
-
-514.79K
25.27%
investments in property plant and equipment
acquisitions net
purchases of investments
sales maturities of investments
other investing activites
-127.55M
-
net cash used for investing activites
-127.55M
-
debt repayment
-37.81K
-
common stock issued
132.10M
-
common stock repurchased
dividends paid
other financing activites
-2.96M
-
-45K
98.48%
net cash used provided by financing activities
129.10M
-
-45K
100.03%
effect of forex changes on cash
net change in cash
868.28K
-
-559.79K
164.47%
cash at beginning of period
868.28K
-
cash at end of period
868.28K
-
308.49K
64.47%
operating cash flow
-688.83K
-
-514.79K
25.27%
capital expenditure
free cash flow
-688.83K
-
-514.79K
25.27%

All numbers in (except ratios and percentages)